N. Mitsuhata

A genome-wide association study identifies four genetic markers for hematological toxicities in cancer patients receiving gemcitabine therapy

Yusuke Nakamura, T. Mushiroda, M. Kubo, 2012, Pharmacogenetics and genomics.

STUDIES ON THE EFFECTS OF ANTICANCER COMBINATION CHEMOTHERAPY AND RADIOTHERAPY ON HYPOTHALAMO-PITUITARY-GONADAL AXIS AND ADRENOCORTICAL FUNCTION IN MALE GENITOURINARY CANCER PATIENTS

N. Mitsuhata, Hiroyuki Ohmori, 2010 .

Delayed-onset neutropenia in a patient receiving rituximab as treatment for refractory kidney transplantation.

N. Mitsuhata, R. Fujita, S. Ito, 2005, Transplantation.

Last Resort for Renal Transplant Recipients, ‘Restored Kidneys’ from Living Donors/Patients

Y. Tsutsumi, S. Fujita, N. Mitsuhata, 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

A phase I/II study of cancer peptide vaccine S-288310 in patients with advanced urothelial carcinoma of the bladder

Teruhiko Yoshida, T. Miki, T. Shuin, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Is Administration of Rituximab at 375 mg/m2 Without Splenectomy Appropriate for ABO‐Incompatible Renal Transplant?

N. Mitsuhata, K. Kojima, R. Fujita, 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

An ABO incompatible renal transplant from a living donor for atypical hemolytic uremic syndrome resulted in graft loss because of hyperacute humoral rejection

T. Higashi, N. Mitsuhata, Y. Mikawa, 2002 .

[Plasma 11-deoxycortisol response to single dose metyrapone in prostatic cancer patients (author's transl)].

N. Mitsuhata, T. Takami, M. Morioka, 1981, Nihon Naibunpi Gakkai zasshi.

Intravesical treatment of bladder cancer with recombinant human interferon-β

H. Ueda, S. Kagawa, T. Niijima, 1989, Cancer Immunology, Immunotherapy.

Intra-arterial infusion chemotherapy in combination with angiotensin II for advanced bladder cancer.

M. Seki, N. Mitsuhata, Y. Matsumura, 1986, The Journal of urology.

Donor kidneys with small renal cell cancer or low-grade lower ureteral cancer can be transplanted.

N. Mitsuhata, K. Kojima, S. Ito, 2007, Transplantation.

A case of suspected vascular rejection after ABO-incompatible living renal transplantation treated with a series of 8 plasma exchanges

T. Higashi, N. Mitsuhata, M. Miyazaki, 2003 .

Transplantation of Restored Kidneys From Unrelated Donors After Resection of Renal Cell Carcinoma: Results From 10 Patients.

N. Mitsuhata, H. Afuso, Y. Ogawa, 2015, Transplantation proceedings.

What Disease Conditions could be Considered for Potential Therapeutic Kidney Donations

N. Mitsuhata, Y. Ogawa, M. Mannami, 2016 .